MorphoSys Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Apr 24 | BuyUS$314,955,281 | Novartis AG | Company | 4,360,100 | US$72.25 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 235,483 | 0.468% |
Individual Insiders | 993,318 | 1.97% |
Hedge Funds | 1,890,000 | 3.76% |
Public Companies | 5,697,652 | 11.3% |
Institutions | 41,506,148 | 82.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,058,671 | US$367.2m | 11.9% | 28.64% | |||
4,360,100 | US$316.5m | 449% | no data | |||
3,676,240 | US$266.8m | 27.5% | 0.02% | |||
3,434,605 | US$249.3m | 177% | 0.34% | |||
2,821,618 | US$204.8m | 45.3% | 0.17% | |||
2,447,885 | US$177.7m | -21.4% | 0.02% | |||
2,175,892 | US$157.9m | 153% | 0.01% | |||
1,890,000 | US$137.2m | 26% | 0.27% | |||
1,880,107 | US$136.5m | 36,400% | 0.21% | |||
1,861,472 | US$135.1m | -20.5% | 0.02% | |||
1,711,331 | US$124.2m | 0% | 1.59% | |||
1,439,363 | US$104.5m | 40,700% | 0.16% | |||
1,391,155 | US$101.0m | 10.3% | no data | |||
1,337,552 | US$97.1m | 0% | no data | |||
1,337,552 | US$97.1m | 0% | 35.61% | |||
1,192,607 | US$86.6m | -43.1% | 0.03% | |||
1,010,913 | US$73.4m | 0% | 0.06% | |||
999,755 | US$72.6m | 1,900% | 0.16% | |||
985,701 | US$71.5m | -13.8% | 0.05% | |||
979,174 | US$71.1m | 3.38% | 0.02% | |||
975,441 | US$70.8m | -7.8% | no data | |||
927,821 | US$67.3m | 0% | no data | |||
835,292 | US$60.6m | 0% | 0.03% | |||
711,354 | US$51.6m | -11% | no data | |||
374,766 | US$27.2m | 31.9% | 0.03% |